Atlas Capital Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
Atlas Capital Advisors's OGN Position: Q2 2026 in Review
Atlas Capital Advisors increased its Organon & Co (OGN) stake by 1,818% in Q2 2026, buying an estimated $96.7K and bringing the position to 8,533 shares worth $116K. The position accounts for 0.01% of the portfolio, ranked #574.
Atlas Capital Advisors first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $462K in Q3 2024. 635 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Atlas Capital Advisors held 8,533 shares of Organon & Co worth $116K as of Q2 2026.
- Atlas Capital Advisors bought 8,088 Organon & Co shares in Q2 2026, an estimated $96.7K.
- Organon & Co made up 0.01% of Atlas Capital Advisors's portfolio in Q2 2026, its #574 holding.
- Atlas Capital Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- Atlas Capital Advisors's Organon & Co position peaked at $462K in Q3 2024.
- 635 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.